Arsenic interaction with zinc finger motifs

Arsenic: Exposure Sources, Health Risks, and Mechanisms of Toxicity

Volumn , Issue , 2015, Pages 289-314

  Hudson, Laurie G ^a   Cooper, Karen L ^a   Atlas, Susan R ^a   King, Brenee S ^b   Liu, Ke Jian ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

Arsenic interaction; DNA repair inhibition; Steroid hormone receptors; Zinc finger motifs

Indexed keywords

ALKYLATION; DNA; ENDOCRINOLOGY; PROTEINS; REPAIR; STEROID HORMONES; ZINC;

DNA REPAIR; EXPERIMENTAL EVIDENCE; INORGANIC ARSENIC; METHYLTRANSFERASES; STEROID HORMONE RECEPTORS; XERODERMA PIGMENTOSUM GROUP A; ZINC FINGER MOTIFS; ZINC FINGER PROTEIN;

ARSENIC;

EID: 85018236528     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118876992.ch13     Document Type: Chapter

References (134)

1. Agency for Toxic Substances and Disease Registry. EPA Report Toxicological Profile for Arsenic. US Department of Health and Human Services, Public Health Service Agency for Toxic Substances and Disease Registry, Atlanta, GA, 2007.
2. A.A. Ali, G. Timinszky, R. Arribas-Bosacoma, M. Kozlowski, P.O. Hassa, M. Hassler, A.G. Ladurner, L.H. Pearl, A.W. Oliver, The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks, Nat Struct Mol Biol 19 (2012) 685-692.
3. A.I. Anzellotti, N.P. Farrell, Zinc metalloproteins as medicinal targets, Chem Soc Rev 37 (2008) 1629-1651.
4. H.V. Aposhian, R.A. Zakharyan, M.D. Avram, A. Sampayo-Reyes, M.L. Wollenberg, A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species, Toxicol Appl Pharmacol 198 (2004) 327-335.
5. M. Asmuss, L.H. Mullenders, A. Eker, A. Hartwig, Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair, Carcinogenesis 21 (2000) 2097-2104.
6. M. Asmuss, L.H. Mullenders, A. Hartwig, Interference by toxic metal compounds with isolated zinc finger DNA repair proteins, Toxicol Lett 112-113 (2000) 227-231.
7. F. Bertolero, G. Pozzi, E. Sabbioni, U. Saffiotti, Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation, Carcinogenesis 8 (1987) 803-808.
8. D. Beyersmann, A. Hartwig, Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms, Arch Toxicol 82 (2008) 493-512.
9. J.E. Bodwell, L.A. Kingsley, J.W. Hamilton, Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain, Chem Res Toxicol 17 (2004) 1064-1076.
10. J.E. Bodwell, J.A. Gosse, A.P. Nomikos, J.W. Hamilton, Arsenic disruption of steroid receptor gene activation: complex dose-response effects are shared by several steroid receptors, Chem Res Toxicol 19 (2006) 1619-1629.
11. M.E. Bonicalzi, J.F. Haince, A. Droit, G.G. Poirier, Regulation of poly(ADP-ribose) metabolism by poly(ADP-ribose) glycohydrolase: where and when? Cell Mol Life Sci 62 (2005) 739-750.
12. T.G. Bredfeldt, B. Jagadish, K.E. Eblin, E.A. Mash, A.J. Gandolfi, Monomethylarsonous acid induces transformation of human bladder cells, Toxicol Appl Pharmacol 216 (2006) 69-79.
13. U. Camenisch, H. Nageli, XPA gene, its product and biological roles, Adv Exp Med Biol 637 (2008) 28-38.
14. Y. Chervona, A. Arita, M. Costa, Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium, Metallomics 4 (2012) 619-627.
15. S.K. Chow, J.Y. Chan, K.P. Fung, Suppression of cell proliferation and regulation of estrogen receptor alpha signaling pathway by arsenic trioxide on human breast cancer MCF-7 cells, J Endocrinol 182 (2004) 325-337.
16. S.K. Chow, J.Y. Chan, K.P. Fung, Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells, J Cell Biochem 93 (2004) 173-187.
17. N.J. Clark, M. Kramer, U.M. Muthurajan, K. Luger, Alternative modes of binding of poly(ADP-ribose) polymerase 1 to free DNA and nucleosomes, J Biol Chem 287 (2012) 32430-32439.
18. S.M. Cohen, L.L. Arnold, M. Eldan, A.S. Lewis, B.D. Beck, Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment, Crit Rev Toxicol 36 (2006) 99-133.
19. S.M. Cohen, T. Ohnishi, L.L. Arnold, X.C. Le, Arsenic-induced bladder cancer in an animal model, Toxicol Appl Pharmacol 222 (2007) 258-263.
20. K.L. Cooper, B.S. King, M.M. Sandoval, K.J. Liu, L.G. Hudson, Reduction of arseniteenhanced ultraviolet radiation DNA damage by supplemental zinc, Toxicol Appl Pharmacol 269 (2013) 81-88.
21. I. Csanaky, Z. Gregus, Role of glutathione in reduction of arsenate and of gammaglutamyltranspeptidase in disposition of arsenite in rats, Toxicology 207 (2005) 91-104.
22. D. Damours, S. Desnoyers, I. Dsilva, G.G. Poirier, Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions, Biochem J 342 (Pt 2) (1999) 249-268.
23. S.U. Dani, The arsenic for phosphorus swap is accidental, rather than a facultative one, and the question whether arsenic is nonessential or toxic is quantitative, not a qualitative one, Sci Total Environ 409 (2011) 4889-4890.
24. J.C. Davey, J.E. Bodwell, J.A. Gosse, J.W. Hamilton, Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture, Toxicol Sci 98 (2007) 75-86.
25. H. de The, M. Le Bras, V. Lallemand-Breitenbach, The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies, J Cell Biol 198 (2012) 11-21.
26. M. De Vos, V. Schreiber, F. Dantzer, The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art, Biochem Pharmacol 84 (2012) 137-146.
27. M. Delnomdedieu, M.M. Basti, J.D. Otvos, D.J. Thomas, Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study, Chem Biol Interact 90 (1994) 139-155.
28. C. Demicheli, F. Frezard, F.A. Pereira, D.M. Santos, J.B. Mangrum, N.P. Farrell, Interaction of arsenite with a zinc finger CCHC peptide: evidence for formation of an As-Zn-peptide mixed complex, J Inorg Biochem 105 (2011) 1753-1758.
29. P.J. Dilda, P.J. Hogg, Arsenical-based cancer drugs, Cancer Treat Rev 33 (2007) 542-564.
30. W. Ding, L.G. Hudson, X. Sun, C. Feng, K.J. Liu, As(III) inhibits ultraviolet radiationinduced cyclobutane pyrimidine dimer repair via generation of nitric oxide in human keratinocytes, Free Radic Biol Med 45 (2008) 1065-1072.
31. W. Ding, W. Liu, K.L. Cooper, X.J. Qin, P.L. de Souza Bergo, L.G. Hudson, K.J. Liu, Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage, J Biol Chem 284 (2009) 6809-6817.
32. E. Dopp, A.D. Kligerman, R.A. Diaz-Bone, Organoarsenicals. Uptake, metabolism, and toxicity, Met Ions Life Sci 7 (2010) 231-265.
33. Z. Drobna, F.S. Walton, D.S. Paul, W. Xing, D.J. Thomas, M. Styblo, Metabolism of arsenic in human liver: the role of membrane transporters, Arch Toxicol 84 (2010) 3-16.
34. I.L. Druwe, R.R. Vaillancourt, Influence of arsenate and arsenite on signal transduction pathways: an update, Arch Toxicol 84 (2010) 585-596.
35. T.R. Durham, E.T. Snow, Metal ions and carcinogenesis, EXS (2006) 97-130.
36. K.E. Eblin, T.G. Bredfeldt, A.J. Gandolfi, Immortalized human urothelial cells as a model of arsenic-induced bladder cancer, Toxicology 248 (2008) 67-76.
37. C. Escudero-Lourdes, M.K. Medeiros, M.C. Cardenas-Gonzalez, S.M. Wnek, J.A. Gandolfi, Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model, Toxicol Appl Pharmacol 244 (2010) 162-173.
38. S. Eustermann, H. Videler, J.C. Yang, P.T. Cole, D. Gruszka, D. Veprintsev, D. Neuhaus, The DNA-binding domain of human PARP-1 interacts with DNA single-strand breaks as a monomer through its second zinc finger, J Mol Biol 407 (2011) 149-170.
39. S.J. Flora, Arsenic-induced oxidative stress and its reversibility, Free Radic Biol Med 51 (2011) 257-281.
40. M. Genestra, Oxyl radicals, redox-sensitive signalling cascades and antioxidants, Cell Signal 19 (2007) 1807-1819.
41. N. Goosen, Scanning the DNA for damage by the nucleotide excision repair machinery, DNA Repair (Amst) 9 (2010) 593-596.
42. A. Hartmann, G. Speit, Effect of arsenic and cadmium on the persistence of mutageninduced DNA lesions in human cells, Environ Mol Mutagen 27 (1996) 98-104.
43. A. Hartwig, U.D. Groblinghoff, D. Beyersmann, A.T. Natarajan, R. Filon, L.H. Mullenders, Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts, Carcinogenesis 18 (1997) 399-405.
44. A. Hartwig, M. Asmuss, I. Ehleben, U. Herzer, D. Kostelac, A. Pelzer, T. Schwerdtle, A. Burkle, Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms, Environ Health Perspect 110 (Suppl 5) (2002) 797-799.
45. A. Hartwig, A. Pelzer, M. Asmuss, A. Burkle, Very low concentrations of arsenite suppress poly(ADP-ribosyl)ation in mammalian cells, Int J Cancer 104 (2003) 1-6.
46. A.V. Hirner, A.W. Rettenmeier, Methylated metal(loid) species in humans, Met Ions Life Sci 7 (2010) 465-521.
47. C. Huang, Q. Ke, M. Costa, X. Shi, Molecular mechanisms of arsenic carcinogenesis, Mol Cell Biochem 255 (2004) 57-66.
48. M.F. Hughes, E.M. Kenyon, B.C. Edwards, C.T. Mitchell, L.M. Razo, D.J. Thomas, Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate, Toxicol Appl Pharmacol 191 (2003) 202-210.
49. W. Humphrey, A. Dalke, K. Schulten, VMD: visual molecular dynamics, J Mol Graph 14 (1996) 33-38, 27-38.
50. I. Iavicoli, L. Fontana, A. Bergamaschi, The effects of metals as endocrine disruptors, J Toxicol Environ Health B Crit Rev 12 (2009) 206-223.
51. T. Ikegami, I. Kuraoka, M. Saijo, N. Kodo, Y. Kyogoku, K. Morikawa, K. Tanaka, M. Shirakawa, Solution structure of the DNA-and RPA-binding domain of the human repair factor XPA, Nat Struct Biol 5 (1998) 701-706.
52. S. Iuchi, Three classes of C2H2 zinc finger proteins, Cell Mol Life Sci 58 (2001) 625-635.
53. M. Javle, N.J. Curtin, The role of PARP in DNA repair and its therapeutic exploitation, Br J Cancer 105 (2011) 1114-1122.
54. M. Jeanne, V. Lallemand-Breitenbach, O. Ferhi, M. Koken, M. Le Bras, S. Duffort, L. Peres, C. Berthier, H. Soilihi, B. Raught, H. de The, PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3, Cancer Cell 18 (2010) 88-98.
55. K. Jomova, Z. Jenisova, M. Feszterova, S. Baros, J. Liska, D. Hudecova, C.J. Rhodes, M. Valko, Arsenic: toxicity, oxidative stress and human disease, J Appl Toxicol 31 (2011) 95-107.
56. R.C. Kaltreider, A.M. Davis, J.P. Lariviere, J.W. Hamilton, Arsenic alters the function of the glucocorticoid receptor as a transcription factor, Environ Health Perspect 109 (2001) 245-251.
57. T. Kamimura, T. Miyamoto, M. Harada, K. Akashi, Advances in therapies for acute promyelocytic leukemia, Cancer Sci 102 (2011) 1929-1937.
58. S. Kapaj, H. Peterson, K. Liber, P. Bhattacharya, Human health effects from chronic arsenic poisoning-a review, J Environ Sci Health A Tox Hazard Subst Environ Eng 41 (2006) 2399-2428.
59. K.T. Kitchin, K. Wallace, Arsenite binding to synthetic peptides based on the Zn finger region and the estrogen binding region of the human estrogen receptor-alpha, Toxicol Appl Pharmacol 206 (2005) 66-72.
60. K.T. Kitchin, K. Wallace, Dissociation of arsenite-peptide complexes: triphasic nature, rate constants, half-lives, and biological importance, J Biochem Mol Toxicol 20 (2006) 48-56.
61. K.T. Kitchin, K. Wallace, The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity, J Inorg Biochem 102 (2008) 532-539.
62. K.T. Kitchin, R. Conolly, Arsenic-induced carcinogenesis-oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment, Chem Res Toxicol 23 (2010) 327-335.
63. A.D. Kligerman, C.L. Doerr, A.H. Tennant, K. Harrington-Brock, J.W. Allen, E. Winkfield, P. Poorman-Allen, B. Kundu, K. Funasaka, B.C. Roop, M.J. Mass, D.M. DeMarini, Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations, Environ Mol Mutagen 42 (2003) 192-205.
64. A. Klug, The discovery of zinc fingers and their applications in gene regulation and genome manipulation, Annu Rev Biochem 79 (2010) 213-231.
65. S.S. Krishna, I. Majumdar, N.V. Grishin, Structural classification of zinc fingers: survey and summary, Nucleic Acids Res 31 (2003) 532-550.
66. Y. Kumagai, D. Sumi, Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity, Annu Rev Pharmacol Toxicol 47 (2007) 243-262.
67. R. Kumar, I.J. McEwan, Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation, Endocr Rev 33 (2012) 271-299.
68. J.H. Laity, B.M. Lee, P.E. Wright, Zinc finger proteins: new insights into structural and functional diversity, Curr Opin Struct Biol 11 (2001) 39-46.
69. V. Lallemand-Breitenbach, J. Zhu, Z. Chen, H. de The, Curing APL through PML/RARA degradation by As2O3, Trends Mol Med 18 (2012) 36-42.
70. M.F. Langelier, K.M. Servent, E.E. Rogers, J.M. Pascal, A third zinc-binding domain of human poly(ADP-ribose) polymerase-1 coordinates DNA-dependent enzyme activation, J Biol Chem 283 (2008) 4105-4114.
71. M.F. Langelier, D.D. Ruhl, J.L. Planck, W.L. Kraus, J.M. Pascal, The Zn3 domain of human poly(ADP-ribose) polymerase-1 (PARP-1) functions in both DNA-dependent poly(ADP-ribose) synthesis activity and chromatin compaction, J Biol Chem 285 (2010) 18877-18887.
72. M.F. Langelier, J.L. Planck, S. Roy, J.M. Pascal, Crystal structures of poly(ADP-ribose) polymerase-1 (PARP-1) zinc fingers bound to DNA: structural and functional insights into DNA-dependent PARP-1 activity, J Biol Chem 286 (2011) 10690-10701.
73. S.F. Lee-Chen, C.T. Yu, K.Y. Jan, Effect of arsenite on the DNA repair of UV-irradiated Chinese hamster ovary cells, Mutagenesis 7 (1992) 51-55.
74. W. Lilyestrom, M.J. van der Woerd, N. Clark, K. Luger, Structural and biophysical studies of human PARP-1 in complex with damaged DNA, J Mol Biol 395 (2010) 983-994.
75. J.X. Liu, G.B. Zhou, S.J. Chen, Z. Chen, Arsenic compounds: revived ancient remedies in the fight against human malignancies, Curr Opin Chem Biol 16 (2012) 92-98.
76. S. Lopez, Y. Miyashita, S.S. Simons, Jr., Structurally based, selective interaction of arsenite with steroid receptors, J Biol Chem 265 (1990) 16039-16042.
77. A. Ludwig, B. Behnke, J. Holtlund, H. Hilz, Immunoquantitation and size determination of intrinsic poly(ADP-ribose) polymerase from acid precipitates. An analysis of the in vivo status in mammalian species and in lower eukaryotes, J Biol Chem 263 (1988) 6993-6999.
78. N.W. Luedtke, R.J. Dexter, D.B. Fried, A. Schepartz, Surveying polypeptide and protein domain conformation and association with FlAsH and ReAsH, Nat Chem Biol 3 (2007) 779-784.
79. J.P. Mackay, M. Crossley, Zinc fingers are sticking together, Trends Biochem Sci 23 (1998) 1-4.
80. A. Maier, B.L. Schumann, X. Chang, G. Talaska, A. Puga, Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity, Mutat Res 517 (2002) 101-111.
81. B.K. Mandal, Y. Ogra, K. Anzai, K.T. Suzuki, Speciation of arsenic in biological samples, Toxicol Appl Pharmacol 198 (2004) 307-318.
82. W. Maret, Exploring the zinc proteome, J Anal At Spectrom 19 (2004) 15-19.
83. J.H. Martens, A.B. Brinkman, F. Simmer, K.J. Francoijs, A. Nebbioso, F. Ferrara, L. Altucci, H.G. Stunnenberg, PML-RARalpha/RXR alters the epigenetic landscape in acute promyelocytic leukemia, Cancer Cell 17 (2010) 173-185.
84. B.R. Martin, B.N. Giepmans, S.R. Adams, R.Y. Tsien, Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity, Nat Biotechnol 23 (2005) 1308-1314.
85. J.M. Matthews, M. Sunde, Zinc fingers-folds for many occasions, IUBMB Life 54 (2002) 351-355.
86. I.J. McEwan, Nuclear receptors: one big family, Methods Mol Biol 505 (2009) 3-18.
87. J.H. Mikesch, H. Gronemeyer, C.W. So, Discovery of novel transcriptional and epigenetic targets in APL by global ChIP analyses: emerging opportunity and challenge, Cancer Cell 17 (2010) 112-114.
88. J. Miller, A.D. McLachlan, A. Klug, Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes, EMBO J 4 (1985) 1609-1614.
89. E. Mitchell, S. Frisbie, B. Sarkar, Exposure to multiple metals from groundwater-a global crisis: geology, climate change, health effects, testing, and mitigation, Metallomics 3 (2011) 874-908.
90. I. Miyamoto, N. Miura, H. Niwa, J. Miyazaki, K. Tanaka, Mutational analysis of the structure and function of the xeroderma pigmentosum group A complementing protein. Identification of essential domains for nuclear localization and DNA excision repair, J Biol Chem 267 (1992) 12182-12187.
91. D.J. Mustra, A.J. Warren, D.E. Wilcox, J.W. Hamilton, Preferential binding of human XPA to the mitomycin C-DNA interstrand crosslink and modulation by arsenic and cadmium, Chem Biol Interact 168 (2007) 159-168.
92. S. Oka, Y. Shiraishi, T. Yoshida, T. Ohkubo, Y. Sugiura, Y. Kobayashi, NMR structure of transcription factor Sp1 DNA binding domain, Biochemistry 43 (2004) 16027-16035.
93. T. Okui, Y. Fujiwara, Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells, Mutat Res 172 (1986) 69-76.
94. C.J. Park, B.S. Choi, The protein shuffle. Sequential interactions among components of the human nucleotide excision repair pathway, FEBS J 273 (2006) 1600-1608.
95. T.J. Patterson, M. Ngo, P.A. Aronov, T.V. Reznikova, P.G. Green, R.H. Rice, Biological activity of inorganic arsenic and antimony reflects oxidation state in cultured human keratinocytes, Chem Res Toxicol 16 (2003) 1624-1631.
96. J. Pi, B.A. Diwan, Y. Sun, J. Liu, W. Qu, Y. He, M. Styblo, M.P. Waalkes, Arsenicinduced malignant transformation of human keratinocytes: involvement of Nrf2, Free Radic Biol Med 45 (2008) 651-658.
97. K. Piatek, T. Schwerdtle, A. Hartwig, W. Bal, Monomethylarsonous acid destroys a tetrathiolate zinc finger much more efficiently than inorganic arsenite: mechanistic considerations and consequences for DNA repair inhibition, Chem Res Toxicol 21 (2008) 600-606.
98. L.C. Platanias, Biological responses to arsenic compounds, J Biol Chem 284 (2009) 18583-18587.
99. E. Puccetti, M. Ruthardt, Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell, Leukemia 18 (2004) 1169-1175.
100. X.J. Qin, L.G. Hudson, W. Liu, G.S. Timmins, K.J. Liu, Low concentration of arsenite exacerbates UVR-induced DNA strand breaks by inhibiting PARP-1 activity, Toxicol Appl Pharmacol 232 (2008) 41-50.
101. S.M. Quintal, Q.A. dePaula, N.P. Farrell, Zinc finger proteins as templates for metal ion exchange and ligand reactivity. Chemical and biological consequences, Metallomics 3 (2011) 121-139.
102. J.F. Reichard, A. Puga, Effects of arsenic exposure on DNA methylation and epigenetic gene regulation, Epigenomics 2 (2010) 87-104.
103. X. Ren, C.M. McHale, C.F. Skibola, A.H. Smith, M.T. Smith, L. Zhang, An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis, Environ Health Perspect 119 (2011) 11-19.
104. T.G. Rossman, Enhancement of UV-mutagenesis by low concentrations of arsenite in E. coli, Mutat Res 91 (1981) 207-211.
105. T.G. Rossman, C.B. Klein, Genetic and epigenetic effects of environmental arsenicals, Metallomics 3 (2011) 1135-1141.
106. T. Sakurai, S. Himeno, Endocrine disruptive effects of inorganic arsenicals, Environ Sci 13 (2006) 101-106.
107. K. Salnikow, A. Zhitkovich, Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium, Chem Res Toxicol 21 (2008) 28-44.
108. V. Schreiber, F. Dantzer, J.C. Ame, G. de Murcia, Poly(ADP-ribose): novel functions for an old molecule, Nat Rev Mol Cell Biol 7 (2006) 517-528.
109. T. Schwerdtle, I. Walter, A. Hartwig, Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg, DNA Repair (Amst) 2 (2003) 1449-1463.
110. N. Scott, K.M. Hatlelid, N.E. MacKenzie, D.E. Carter, Reactions of arsenic(III) and arsenic(V) species with glutathione, Chem Res Toxicol 6 (1993) 102-106.
111. S.M. Shell, Y. Zou, Other proteins interacting with XP proteins, Adv Exp Med Biol 637 (2008) 103-112.
112. H. Shi, L.G. Hudson, K.J. Liu, Oxidative stress and apoptosis in metal ion-induced carcinogenesis, Free Radic Biol Med 37 (2004) 582-593.
113. H. Shi, X. Shi, K.J. Liu, Oxidative mechanism of arsenic toxicity and carcinogenesis, Mol Cell Biochem 255 (2004) 67-78.
114. M. Shrivastav, L.P. De Haro, J.A. Nickoloff, Regulation of DNA double-strand break repair pathway choice, Cell Res 18 (2008) 134-147.
115. S.S. Simons, Jr., P.K. Chakraborti, A.H. Cavanaugh, Arsenite and cadmium(II) as probes of glucocorticoid receptor structure and function, J Biol Chem 265 (1990) 1938-1945.
116. V. Stanisic, D.M. Lonard, B.W. Omalley, Modulation of steroid hormone receptor activity, Prog Brain Res 181 (2010) 153-176.
117. J.C. States, A. Barchowsky, I.L. Cartwright, J.F. Reichard, B.W. Futscher, R.C. Lantz, Arsenic toxicology: translating between experimental models and human pathology, Environ Health Perspect 119 (2011) 1356-1363.
118. M. Styblo, L.M. Del Razo, L. Vega, D.R. Germolec, E.L. LeCluyse, G.A. Hamilton, W. Reed, C. Wang, W.R. Cullen, D.J. Thomas, Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells, Arch Toxicol 74 (2000) 289-299.
119. K. Tanaka, N. Miura, I. Satokata, I. Miyamoto, M.C. Yoshida, Y. Satoh, S. Kondo, A. Yasui, H. Okayama, Y. Okada, Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain, Nature 348 (1990) 73-76.
120. Z. Tao, P. Gao, D.W. Hoffman, H.W. Liu, Domain C of human poly(ADP-ribose) polymerase-1 is important for enzyme activity and contains a novel zinc-ribbon motif, Biochemistry 47 (2008) 5804-5813.
121. E.J. Tokar, L. Benbrahim-Tallaa, J.M. Ward, R. Lunn, R.L. Sams, 2nd, M.P. Waalkes, Cancer in experimental animals exposed to arsenic and arsenic compounds, Crit Rev Toxicol 40 (2010) 912-927.
122. E.J. Tokar, W. Qu, M.P. Waalkes, Arsenic, stem cells, and the developmental basis of adult cancer, Toxicol Sci 120 (Suppl 1) (2011) S192-S203.
123. M. Valko, C.J. Rhodes, J. Moncol, M. Izakovic, M. Mazur, Free radicals, metals and antioxidants in oxidative stress-induced cancer, Chem Biol Interact 160 (2006) 1-40.
124. I. Walter, T. Schwerdtle, C. Thuy, J.L. Parsons, G.L. Dianov, A. Hartwig, Impact of arsenite and its methylated metabolites on PARP-1 activity, PARP-1 gene expression and poly(ADP-ribosyl)ation in cultured human cells, DNA Repair (Amst) 6 (2007) 61-70.
125. T.C. Wang, J.S. Huang, V.C. Yang, H.J. Lan, C.J. Lin, K.Y. Jan, Delay of the excision of UV light-induced DNA adducts is involved in the coclastogenicity of UV light plus arsenite, Int J Radiat Biol 66 (1994) 367-372.
126. W.H. Watson, J.D. Yager, Arsenic: extension of its endocrine disruption potential to interference with estrogen receptor-mediated signaling, Toxicol Sci 98 (2007) 1-4.
127. A. Witkiewicz-Kucharczyk, W. Bal, Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis, Toxicol Lett 162 (2006) 29-42.
128. S.M. Wnek, C.L. Kuhlman, J.M. Camarillo, M.K. Medeiros, K.J. Liu, S.S. Lau, A.J. Gandolfi, Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells, Toxicol Appl Pharmacol 257 (2011) 1-13.
129. R.D. Wood, Mammalian nucleotide excision repair proteins and interstrand crosslink repair, Environ Mol Mutagen 51 (2010) 520-526.
130. J.W. Yager, J.K. Wiencke, Enhancement of chromosomal damage by arsenic: implications for mechanism, Environ Health Perspect 101 (Suppl 3) (1993) 79-82.
131. X.W. Zhang, X.J. Yan, Z.R. Zhou, F.F. Yang, Z.Y. Wu, H.B. Sun, W.X. Liang, A.X. Song, V. Lallemand-Breitenbach, M. Jeanne, Q.Y. Zhang, H.Y. Yang, Q.H. Huang, G.B. Zhou, J.H. Tong, Y. Zhang, J.H. Wu, H.Y. Hu, H. de The, S.J. Chen, Z. Chen, Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML, Science 328 (2010) 240-243.
132. L. Zhao, S. Chen, L. Jia, S. Shu, P. Zhu, Y. Liu, Selectivity of arsenite interaction with zinc finger proteins, Metallomics 4 (2012) 988-994.
133. X. Zhou, X. Sun, K.L. Cooper, F. Wang, K.J. Liu, L.G. Hudson, Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs, J Biol Chem 286 (2011) 22855-22863.
134. X. Zhou, X. Sun, C. Mobarak, A.J. Gandolfi, S.W. Burchiel, L.G. Hudson, K.J. Liu. Differential binding of monomethylarsonous acid compared to arsenite and arsenic trioxide with zinc finger peptides and proteins. Chem Res Toxicol 27(4) (2014) 690-698.